Jiangsu Cancer Hospital — Nanjing, Jiangsu

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Nanjing →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Jiangsu Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

240

Registered studies

90

Active

47

Recruiting now

81

Completed

19

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Locally Advanced or Metastatic Breast Cancer · Esophageal Squamous Cell Carcinoma (ESCC) · Recurrent or Metastatic Gastric or Gastroesophageal Junction…

Recently updated registry entries

NCT07060807 — A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) (Recruiting)
NCT06862869 — Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated… (Recruiting)
NCT07564466 — A Study of SKB571 in Participants With Gastrointestinal Tumors (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.